- CEO
- Konstantin Prokhorov
- Full Time Employees
- 14,000
- Sector
- Consumer non-durables
- Industry
- Beverages: alcoholic
- Address
- Building 1 Moscow MC Russian Federation 119180
- IPO Date
- Nov 19, 2007
- Business
- NovaBev Group PJSC engages in the production, wholesale, and retail of alcoholic beverages and related food products primarily in Russia and internationally. The company manufactures and markets a broad portfolio of spirits including vodka under brands such as Beluga, Belenkaya, Doctor August, Myagkov, Orthodox, Russian Ice, Tsar, Snow Owl, Copper Horse, PARKA, Eagle’s Rock, Severnoe Zoloto, Zimnyaya Doroga, Staraya Moskva, SIBERIA, and Arkhangelskaya; brandy under Bastion, Zolotoy Rezerv, Torres, Noy Armenian, Tiflis Treasure, Ardeli, Golden Reserve, and Le Lion de Pierre; wines under Golubitskoe Estate and Tet de Cheval; and tinctures, bitters, absinthe, balsam, gin, liqueur, rum including Ron Barceló, tequila, and whisky such as Troublemaker; it also distributes imported brands like Concha y Toro wines, Frontera, Casillero del Diablo, and Noy cognacs. Founded in 1998 and headquartered in Moscow, Russia, NovaBev Group operates five factories, one ethanol plant, one winery, and its own distribution network including the WineLab retail chain with over 2,000 outlets; it exports to more than 70 countries and targets premium and super-premium segments in the distilled spirits and wine markets. In August 2023, the company changed its name from Public Joint-Stock Company Beluga Group to NovaBev Group PJSC; recent developments include becoming the exclusive distributor in Russia for Concha y Toro's Frontera and Casillero del Diablo wines on July 1, 2024, renewing the exclusive distribution agreement for Noy cognacs for five years, achieving record 2024 revenue of 135.5 billion rubles with sales of 18 million 9L cases, expanding WineLab by opening new stores and growing e-commerce, launching new product collections like Bokaleros, and initiating cybersecurity modernization following a July 2025 cyberattack while reporting 9M 2025 sales of 11.7 million 9L cases.